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We identified an unusual strain of mycobacteria from two
patients with pulmonary tuberculosis by its smooth, glossy mor-
photype and, primarily, its genotypic characteristics. Spoligo-
typing and restriction fragment length polymorphism typing
were carried out with the insertion sequence IS6110 patterns.
All known cases of tuberculosis caused by Mycobacterium
canetti have been contracted in the Horn of Africa.
he Mycobacterium tuberculosis complex includes the fol-
lowing mycobacteria, which are characterized by a slow
growing rate: M. tuberculosis, M. africanum, M. bovis, and M.
microti (1). In recently published reports of two cases of lym-
phatic node tuberculosis (TB), the strains were recognized as
belonging to a new taxon of M. tuberculosis (2,3). These iso-
lates were characterized by a highly particular growing pat-
tern, and the colonies appeared smooth and glossy. A complete
genetic study of these strains led to their integration into the
M. tuberculosis complex. This strain, identified as M. tubercu-
losis subsp. canetti or, more simply, M. canetti, was first iso-
lated in 1969 by Georges Canetti from a French farmer. The
strain was preserved at the Pasteur Institute where its antigenic
pattern was studied extensively. We report two cases of pulmo-
nary TB caused by this strain. The two patients had also lived
in East Africa.
The Study
Patient 1
In September 1998, a 36-year-old male soldier in the
French Foreign Legion with hemoptysis was sent back to
France from Djibouti. He expectorated bloody sputum after
running and on a few other occasions. His medical history was
not unusual. When the patient was hospitalized, 2 weeks after
the initial symptoms, he began to experience progressive
fatigue. He did not experience fever, weight loss, night sweats,
anorexia, cough, dyspnea, or chest pain, and did not produce
sputum.
Results of the clinical examination were normal. The Man-
toux test, performed with 10 IU of purified tuberculin (Aven-
tis-Pasteur-MSD, Lyon, France), yielded a maximum
transverse diameter of induration of 15 mm. Laboratory values
were normal (Table). The chest X-ray showed a triangular con-
solidation of the left upper lobe with blurred limits and small
cavitary lesions. No other contiguous mediastinohilar anoma-
lies were visible. A computed tomographic scan confirmed the
cavitary syndrome: three excavated nodular images showed
radiating spicules within a micronodular infiltrate. Bronchos-
copy showed a moderate inflammation of airway mucosa,
especially in the left upper lobe. Biopsy specimens exhibited
nonspecific inflammation.
A bronchial washing smear from the left upper lobe was
positive for acid-fast bacilli. Serologic tests for HIV-1 and
HIV-2 were negative. No evidence of disease was found else-
where; the patient did not experience bone pain. Results of
neurologic and ophthalmologic examinations were normal; no
lymphadenopathy or hepatosplenomegaly were found and the
genitalia were normal. Auscultation revealed no pericardial
fremitus; no ascitic fluid was detected. The urinary sediment
contained <1,000 red blood cells/L and <5,000 leukocytes/L.
Antituberculosis chemotherapy was begun with four drugs:
rifampicin, isoniazid, ethambutol, and pyrazinamide. Cultures
revealed a strain identified as M. tuberculosis subsp. canetti
that was susceptible to all primary antituberculous drugs.
Therefore, rifampicin and isoniazid were continued for 3 more
months for a total treatment period of 6 months. The patient’s
response to treatment was favorable, and he remained asymp-
tomatic. 
Patient 2
A 55-year-old male soldier in the French Foreign Legion,
who returned from Djibouti, was hospitalized in September
1999 after his chest x-ray showed abnormal findings. He was a
nurse and had been occasionally in charge at the Djibouti Hos-
pital for 2 years. His medical history was unremarkable. Eight
months before he returned to France, he experienced asthenia,
anorexia, and a weight loss of 3 kg. The symptoms resolved
spontaneously after 2 months, and he had been asymptomatic
since then. He had no history of cough, sputum production,
hemoptysis, dyspnea, fever, or night sweats.
Results of a clinical examination and of laboratory studies
were normal (Table), except for hypereosinophilia. Serologic
tests for schistosomiasis, hydatidosis, distomiasis, amebiasis,
toxocariasis, and trichinosis were negative, and parasites were
not found in stool samples. Thoracic radiographs performed
when he came back from Djibouti showed parenchymal con-
solidation of the right upper lobe with small cavities. Sputum
was not produced. A gastric aspirate smear was negative for
acid-fast bacilli, and a bronchial aspiration smear was positive
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for acid-fast bacilli. HIV serology was negative, and no other
site of the infection was found. Drug therapy was initiated
with rifampicin, isoniazid, ethambutol, and pyrazinamide for 2
months. Cultures of bronchial aspirates were positive within
14 days; later, cultures of two gastric aspirates were positive
for acid-fast bacilli. An M. tuberculosis subsp. canetti isolate
was identified, which was susceptible to all primary antituber-
culous drugs. The treatment was then extended for 4 months
with rifampicin and isoniazid. The patient's response to treat-
ment was favorable.
The following methods were used to identify the etiologic
agent. First, the samples were decontaminated with N-acetyl-
L-cysteine/NaOH. Acid-fast bacilli were detected by auramine
staining, the positive smears also were stained with Ziehl-
Nielsen stain. The samples were then seeded onto Löwenstein-
Jensen and Coletsos slants and also into a liquid system, the
BBL Mycobacterial Growth Indicator Tube (MGIT, BD Diag-
nostic Systems, Sparks, MD).
The mycobacteria were identified by using a specific DNA
probe (Gen-Probe, Gen-Probe Incorporated, San Diego, CA)
and by performing the usual biochemical tests (nitrate reduc-
tion, 68°C catalase resistance, niacin production).
The Pasteur Institute of Paris used two methods for typing:
restriction fragment length polymorphism (RFLP) analysis
and spoligotyping. In RFLP analysis, after digestion of the M.
tuberculosis  strain’s genomic DNA with PvuII restriction
enzyme and agarose gel migration, the DNA was transferred
on a membrane, according to the Southern method, and then
hybridized with an insertion sequence IS6110 probe (4). In the
spoligotyping method, after DNA direct repeat amplification,
the labeled polymerase chain reaction product was used as a
probe to hybridize with 43 synthetic spacer oligonucleotides
(DNA sequences derived from the direct repeat [DR] region of
M. tuberculosis, H37Rv and M. bovis BCG P3), which were
attached to a carrier membrane (5). The sensitivity to antitu-
berculous drugs was determined by the indirect proportion
method.
MGIT results were positive for the two cultures in 9 and 12
days, respectively. On Löwenstein-Jensen slants, the cultures
were positive in 12 and 14 days, respectively. The white,
smooth, and glossy colonies were characteristic of M. tubercu-
losis subsp. canetti (Figure 1). The two strains had the same
phenotypic and genotypic pattern; 68°C catalase was negative,
and they reduced nitrate, as do other M. tuberculosis species,
but they did not produce niacin. The DNA probe, Gen-Probe,
confirmed that these strains belonged to the M. tuberculosis
complex.
These strains contained two copies of IS6110. Spoligotyp-
ing showed that they shared only 2 of the 43 oligonucleotides
reproducing the spacer DNA sequences of M. tuberculosis,
Table. Laboratory values for both patients infected with Mycobacte-
rium tuberculosis subsp. canetti
Laboratory test Patient 1 Patient 2
Sedimentation rate (mm) 3 3
C-reactive protein (mg/L) 7.3 4.28
Fibrinogen (g/L) 3.64 6.3
Blood count
Hemoglobin (g/dL) 16.8 14.1
Platelets (x109/L) 194 274
White cells (x109/L) 10.10 9.54
Neutrophils (%) 66.2 69.4
Eosinophils (%) 2 8.6
Lymphocytes (%) 21.3 17.2
Basophils (%) 0.6 0.9
Monocytes (%) 9.9 3.9
Aspartate aminotransferase (U/L) 21 16
Alanine aminotransferase (U/L) 19 23
Creatinine (µmol/L) 89 97
Glucose (mmol/L) 4.7 4.4
Figure 1. Colony morphology on Löwenstein-Jensen slants, showing M.
canetti and M. tuberculosis strains. (A) Colonies of M. tuberculosis are
rough, thick, wrinkled, have an irregular margin, and are faintly buff-col-
ored. (B) M. canetti exhibits smooth, white and glossy colonies.DISPATCHES
1352 Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002
H37Rv and M. bovis BCG P3. This profile is characteristic of
M. tuberculosis subsp. canetti (Figure 2).
Conclusion
In 1997, van Soolingen reported a case of lymph node TB
in a 2-year-old Somali child on the child’s arrival in the Neth-
erlands in 1993 (2). In 1998, Pfyffer described abdominal lym-
phatic TB in a 56-year-old Swiss man (who lived in Kenya)
with stage C2 HIV infection (3). These strains of M. canetti
(So93 from the Somali child and NZM 217/94 from the Swiss
man) have been studied extensively. In culture they grow
faster than other strains in the M. tuberculosis complex. The
So93 strain expands by one rough colony for every 500
smooth colonies. They appear smooth, white, and glossy
because of the high amount of lipooligosaccharides in the
membrane (6); the So93 rough colonies lack this amount (2).
Two copies of the IS6110 insertion sequence were found in
the NZM 217/94 and So93 genome. This fingerprint matched
none of the 5,000 other strains preserved in the laboratory of
van Soolingen (Bilthoven, the Netherlands) (2). The strains we
observed also showed two copies of IS6110. 
So93, NZM 217/94, and our two strains share only 2 of 43
identical repeated sequences that have been observed by spolig-
otyping. Study of the IS6110 RFLP patterns and of the spacer
DNA sequences of the DR locus confirmed that M. tuberculosis,
M. bovis, M. africanum, M. microti, and M. canetti represent a
closely related group of mycobacteria that are clearly distinct
from other mycobacterial species. In the M. tuberculosis com-
plex, M. canetti appears to be the most divergent strain (2).
We believe that this is the first published report of pulmo-
nary disease caused by M. canetti. Our two cases confirm that
M. canetti is able to involve lungs, like any other member of
the M. tuberculosis complex and is able to affect immunocom-
petent subjects. The clinical features of these two pulmonary
cases of TB caused by M. canetti are not specific.
TB caused by M. canetti appears to be an emerging disease
in the Horn of Africa. A history of a visit to the region should
cause this strain to be considered promptly. As travel to this
area becomes more frequent, and mycobacterial identification
techniques improve, the number of diagnosed cases will likely
increase.
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Figure 2. (A) IS6110 hybridization patterns of PvuII-digested genomic
DNA. Lane 1, Mycobacterium tuberculosis Mt 14323 (reference strain).
Lane 2, M. canetti strain NZM 217/94. Lanes 3 and 4, the strains iso-
lated from French legionnaires with pulmonary tuberculosis (TB). (B)
Spoligotyping patterns. Lane 1, M. tuberculosis H37Rv (reference
strain). Lane 2, M. canetti strain NZM 217/94. Lanes 3 and 4, the strains
isolated from French legionnaires with pulmonary TB.